Company Presentation

Medicilon is a fully integrated contract research organization with over 70,000 sqft FDA GLP and non GLP laboratory facility and over 2000 scientists to help novel drug discovery programmes from the till the Investigational New Drug (IND) filing phase include medicinal chemistry, process chemistry, in vitro and in vivo DMPK, preclinical development and bioanalytical support, API synthesis, CMC and preclinical studies for over 1,400 global sponsors.